ANI Pharmaceuticals Inc —— 资产负债表 (NASDAQ:ANIP) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

总资产 461.19 M771.6 M760.09 M904.42 M1.28 B1.44 B 负债总额 265.49 M412.86 M421.55 M446.82 M855.17 M899.65 M 权益总额 195.7 M333.89 M313.69 M432.75 M403.68 M540.72 M 负债及股东权益总额 461.19 M771.6 M760.09 M904.42 M1.28 B1.44 B 总债务 185.69 M287.37 M286.52 M285.67 M318.52 M309.21 M 净债务 177.82 M187.07 M238.29 M64.55 M173.66 M23.63 M

新闻

KYMR Stock Up as FDA Grants Fast Track Designation to Asthma Drug

RVMD Stock Rallies 41% on Positive Phase III Pancreatic Cancer Data

IBRX Stock Rises 7% on Strong Q1 2026 Preliminary Results

ANI Pharmaceuticals Stock: Undervalued Cortrophin Drives Rare Disease Growth (NASDAQ:ANIP)

Zacks.com featured highlights include Intuit, ANI Pharmaceuticals and Gaming and Leisure Properties

Is American Well (AMWL) Outperforming Other Medical Stocks This Year?

Insmed Ends Brinsupri Development in Skin Disease Post Study Failure

ANI Pharmaceuticals Stock: Worthy Of A Position (NASDAQ:ANIP)

Kodiak Q4 Loss Wider Than Expected, Pipeline Development in Focus

AGIO Rises on Mitapivat Progress Toward Accelerated Approval in SCD

AZN Posts Data From Hypophosphatasia Program on Efzimfotase Alfa

ANIP Stock Outlook: Cortrophin Growth vs. Retina Reset